28 results
8-K
KPRX
Kiora Pharmaceuticals Inc
1 Apr 21
EyeGate Pharma Announces the Appointment of Kenneth Gayron and Aron Shapiro to its Board of Directors
6:55am
tenure with Numerex, Mr. Gayron served as CFO of Osmotica Pharmaceutical Corp., a global specialty pharmaceutical company, from October 2013 to February
8-K
EX-3.2
KPRX
Kiora Pharmaceuticals Inc
8 Nov 21
EyeGate is Now Kiora Pharmaceuticals; Provides Update on Company’s
7:32am
, Tenure and Qualifications
Section 3.3
Regular Meetings
Section 3.4
Special Meetings
Section 3.5
Action By Unanimous Consent of Directors
Section 3.6 … by the Corporation.
Section 3.2 Number, Tenure and Qualifications. Subject to the rights of the holders of any series of Preferred Stock to elect
8-K
EX-3.1
KPRX
Kiora Pharmaceuticals Inc
4 Aug 22
Amendments to Articles of Incorporation or Bylaws
4:36pm
, Tenure and Qualifications
Section 3.3
Regular Meetings
Section 3.4
Special Meetings
Section 3.5
Action By Unanimous Consent of Directors
Section 3.6 … by the Corporation.
Section 3.2 Number, Tenure and Qualifications. Subject to the rights of the holders of any series of Preferred Stock to elect additional
8-K
EX-3.2
KPRX
Kiora Pharmaceuticals Inc
20 Feb 15
Amendments to Articles of Incorporation or Bylaws
12:00am
, Tenure and Qualifications
Section 3.3
Regular Meetings
Section 3.4
Special Meetings
Section 3.5
Action By Unanimous Consent of Directors
Section 3.6 … by the Corporation.
Section 3.2 Number, Tenure and Qualifications. Subject to the rights of the holders of any series of Preferred Stock to elect additional
DRS/A
EX-3.4
KPRX
Kiora Pharmaceuticals Inc
8 Jul 14
Draft registration statement (amended)
12:00am
Section 2.11
No Consent of Stockholders in Lieu of Meeting
ARTICLE III BOARD OF DIRECTORS
Section 3.1
General Powers
Section 3.2
Number, Tenure … .
Section 3.2 Number, Tenure and Qualifications. Subject to the rights of the holders of any series of Preferred Stock to elect additional directors
PRE 14A
qhxgj rulfqjfslr6
17 May 18
Preliminary proxy
5:21pm